These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 32612262)

  • 21. Engineered tissues and strategies to overcome challenges in drug development.
    Khalil AS; Jaenisch R; Mooney DJ
    Adv Drug Deliv Rev; 2020; 158():116-139. PubMed ID: 32987094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unexpected partial correction of metabolic and behavioral phenotypes of Alzheimer's APP/PSEN1 mice by gene targeting of diabetes/Alzheimer's-related Sorcs1.
    Knight EM; Ruiz HH; Kim SH; Harte JC; Hsieh W; Glabe C; Klein WL; Attie AD; Buettner C; Ehrlich ME; Gandy S
    Acta Neuropathol Commun; 2016 Feb; 4():16. PubMed ID: 26916443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular genetics of early-onset Alzheimer's disease revisited.
    Cacace R; Sleegers K; Van Broeckhoven C
    Alzheimers Dement; 2016 Jun; 12(6):733-48. PubMed ID: 27016693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systematic genetic study of Alzheimer disease in Latin America: mutation frequencies of the amyloid beta precursor protein and presenilin genes in Colombia.
    Arango D; Cruts M; Torres O; Backhovens H; Serrano ML; Villareal E; Montañes P; Matallana D; Cano C; Van Broeckhoven C; Jacquier M
    Am J Med Genet; 2001 Oct; 103(2):138-43. PubMed ID: 11568920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A critical analysis of new molecular targets and strategies for drug developments in Alzheimer's disease.
    Lahiri DK; Farlow MR; Sambamurti K; Greig NH; Giacobini E; Schneider LS
    Curr Drug Targets; 2003 Feb; 4(2):97-112. PubMed ID: 12558063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The current status of Alzheimer's disease genetics: what do we tell the patients?
    Bertram L; Tanzi RE
    Pharmacol Res; 2004 Oct; 50(4):385-96. PubMed ID: 15304236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted introduction of V642I mutation in amyloid precursor protein gene causes functional abnormality resembling early stage of Alzheimer's disease in aged mice.
    Kawasumi M; Chiba T; Yamada M; Miyamae-Kaneko M; Matsuoka M; Nakahara J; Tomita T; Iwatsubo T; Kato S; Aiso S; Nishimoto I; Kouyama K
    Eur J Neurosci; 2004 May; 19(10):2826-38. PubMed ID: 15147316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel rat model of Alzheimer's disease based on lentiviral-mediated expression of mutant APP.
    Parsi S; Pandamooz S; Heidari S; Naji M; Morfini G; Ahmadiani A; Dargahi L
    Neuroscience; 2015 Jan; 284():99-106. PubMed ID: 25270904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on β-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer's Disease.
    Hansen HH; Fabricius K; Barkholt P; Kongsbak-Wismann P; Schlumberger C; Jelsing J; Terwel D; Termont A; Pyke C; Knudsen LB; Vrang N
    PLoS One; 2016; 11(7):e0158205. PubMed ID: 27421117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preclinical cerebrospinal fluid and volumetric magnetic resonance imaging biomarkers in Swedish familial Alzheimer's disease.
    Thordardottir S; Ståhlbom AK; Ferreira D; Almkvist O; Westman E; Zetterberg H; Eriksdotter M; Blennow K; Graff C
    J Alzheimers Dis; 2015; 43(4):1393-402. PubMed ID: 25182737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dysregulated Metabolism of the Amyloid-β Protein and Therapeutic Approaches in Alzheimer Disease.
    Kikuchi K; Kidana K; Tatebe T; Tomita T
    J Cell Biochem; 2017 Dec; 118(12):4183-4190. PubMed ID: 28488760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetics of Alzheimer's disease.
    Alonso Vilatela ME; López-López M; Yescas-Gómez P
    Arch Med Res; 2012 Nov; 43(8):622-31. PubMed ID: 23142261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Why have transgenic rodent models failed to successfully mimic Alzheimer's disease. How can we develop effective drugs without them?
    Franco R; Martínez-Pinilla E; Navarro G
    Expert Opin Drug Discov; 2019 Apr; 14(4):327-330. PubMed ID: 30775940
    [No Abstract]   [Full Text] [Related]  

  • 34. High striatal amyloid beta-peptide deposition across different autosomal Alzheimer disease mutation types.
    Villemagne VL; Ataka S; Mizuno T; Brooks WS; Wada Y; Kondo M; Jones G; Watanabe Y; Mulligan R; Nakagawa M; Miki T; Shimada H; O'Keefe GJ; Masters CL; Mori H; Rowe CC
    Arch Neurol; 2009 Dec; 66(12):1537-44. PubMed ID: 20008660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mouse models of Alzheimer's disease: a quest for plaques and tangles.
    Richardson JA; Burns DK
    ILAR J; 2002; 43(2):89-99. PubMed ID: 11917160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical phenotype and genetic associations in autosomal dominant familial Alzheimer's disease: a case series.
    Ryan NS; Nicholas JM; Weston PSJ; Liang Y; Lashley T; Guerreiro R; Adamson G; Kenny J; Beck J; Chavez-Gutierrez L; de Strooper B; Revesz T; Holton J; Mead S; Rossor MN; Fox NC
    Lancet Neurol; 2016 Dec; 15(13):1326-1335. PubMed ID: 27777022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetics of early-onset Alzheimer dementia.
    Rademakers R; Cruts M; Van Broeckhoven C
    ScientificWorldJournal; 2003 Jun; 3():497-519. PubMed ID: 12847300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel approaches to models of Alzheimer's disease pathology for drug screening and development.
    Shaughnessy L; Chamblin B; McMahon L; Nair A; Thomas MB; Wakefield J; Koentgen F; Ramabhadran R
    J Mol Neurosci; 2004; 24(1):23-32. PubMed ID: 15314246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic markers for diagnosis and pathogenesis of Alzheimer's disease.
    Kim DH; Yeo SH; Park JM; Choi JY; Lee TH; Park SY; Ock MS; Eo J; Kim HS; Cha HJ
    Gene; 2014 Jul; 545(2):185-93. PubMed ID: 24838203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel mutation in the PSEN2 gene (T430M) associated with variable expression in a family with early-onset Alzheimer disease.
    Ezquerra M; Lleó A; Castellví M; Queralt R; Santacruz P; Pastor P; Molinuevo JL; Blesa R; Oliva R
    Arch Neurol; 2003 Aug; 60(8):1149-51. PubMed ID: 12925374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.